Researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200928152845.htm
No comments:
Post a Comment